which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Neuropsychiatric symptoms commonly complicate Parkinson’s disease (PD), however the presence of such symptoms in mild cognitive impairment (PD-MCI) specifically has not yet been well described. The objective of this study was to examine and compare the prevalence and profile of neuropsychiatric symptoms in patients with PD-MCI (n = 48) to those with PD and no cognitive impairment (PD-NC, n = 54) and to those with dementia in PD (PDD, n = 25). PD-MCI and PDD were defined using specific consensus criteria, and neuropsychiatric symptoms were assessed with the 12-item Neuropsychiatric Inventory (NPI). Self-rated apathy, de...
Objective: We aimed to examine neuropsychiatric symptoms of patients with early and advanced stage P...
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the developm...
Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive performance, which is...
Neuropsychiatric symptoms commonly complicate Parkinson’s disease (PD), however the presence of such...
Neuropsychiatric symptoms (NPS) are common clinical features of Parkinson's disease (PD). However, N...
Parkinson’s disease (PD) is known to cause neuropsychiatric symptoms (NPS). It has been established ...
Neuropsychiatric symptoms (NPS) are a common and potentially serious manifestation of Parkinson's di...
Abstract Background Mild cognitive impairment in Parkinson’s disease (PD-MCI) is a common clinical c...
Subjective memory complaints (SMC) may represent the preclinical phase of Mild Cognitive Impairment ...
This study was undertaken to determine the prevalence and correlates of cognitive impairment (CI) an...
UnlabelledThis study was undertaken to determine the prevalence and correlates of cognitive impairme...
OBJECTIVE: Mild cognitive impairment (MCI) and psychiatric symptoms (anxiety, depression, and apathy...
Objectives—Disturbances of cognition and emotion are common in patients with Parkinson’s disease. Mo...
Objective: To compare Neuropsychiatric symptoms (NPS) in participants with Parkinson’s disease (PD),...
Introduction: Idiopathic Parkinson's disease (PD) is a chronic and progressive neurodegenerative dis...
Objective: We aimed to examine neuropsychiatric symptoms of patients with early and advanced stage P...
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the developm...
Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive performance, which is...
Neuropsychiatric symptoms commonly complicate Parkinson’s disease (PD), however the presence of such...
Neuropsychiatric symptoms (NPS) are common clinical features of Parkinson's disease (PD). However, N...
Parkinson’s disease (PD) is known to cause neuropsychiatric symptoms (NPS). It has been established ...
Neuropsychiatric symptoms (NPS) are a common and potentially serious manifestation of Parkinson's di...
Abstract Background Mild cognitive impairment in Parkinson’s disease (PD-MCI) is a common clinical c...
Subjective memory complaints (SMC) may represent the preclinical phase of Mild Cognitive Impairment ...
This study was undertaken to determine the prevalence and correlates of cognitive impairment (CI) an...
UnlabelledThis study was undertaken to determine the prevalence and correlates of cognitive impairme...
OBJECTIVE: Mild cognitive impairment (MCI) and psychiatric symptoms (anxiety, depression, and apathy...
Objectives—Disturbances of cognition and emotion are common in patients with Parkinson’s disease. Mo...
Objective: To compare Neuropsychiatric symptoms (NPS) in participants with Parkinson’s disease (PD),...
Introduction: Idiopathic Parkinson's disease (PD) is a chronic and progressive neurodegenerative dis...
Objective: We aimed to examine neuropsychiatric symptoms of patients with early and advanced stage P...
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the developm...
Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive performance, which is...